An executive order cutting fertilizer tariffs lowers costs for farmers and indirectly supports demand for farm equipment and ag processing.
The White House issued an executive order suspending tariffs on fertilizers, drawing applause from farm groups. Fertilizer is one of the largest variable costs in crop production — lower input costs improve farm economics, which historically supports both crop planting volumes and capital equipment purchases.
Who cashes in: Deere & Company (DE) is the indirect beneficiary — better farm economics support equipment purchases and reduce the risk of order cancellations. Archer-Daniels-Midland (ADM) and Bunge (BG) process the crops that farmers grow; higher planting volumes driven by improved margins flow through to processing throughput. CF Industries (CF) and Mosaic (MOS), the two largest U.S. fertilizer producers, face a nuanced picture: lower tariffs on imported fertilizer increase competition for domestic producers, but if lower prices stimulate demand enough, volumes could offset the price pressure. The net effect for CF and MOS is probably modestly negative on pricing but worth watching.
Cheaper fertilizer is a cost cut for every American farmer — and what's good for farm economics eventually shows up in Deere order books and ADM processing volumes.
Who's exposed: CF Industries (CF) and Mosaic (MOS) are the names most directly pressured by cheaper imported fertilizer. If the tariff suspension is broad and sustained, it erodes the pricing umbrella that domestic producers have enjoyed. The magnitude depends on which specific fertilizers are covered and for how long.
What to watch next: The specific scope of the executive order — which fertilizer types, which countries of origin, and whether the suspension has an expiration date. A narrow, time-limited suspension is a non-event for CF and MOS. A broad, open-ended one is a real margin headwind.
Source: original report ↗
Free alerts Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/mo Join the owners who run ahead of the industry. Cancel anytime, one click.